Smith Devin Whittemore 4
4 · IO Biotech, Inc. · Filed Jan 13, 2023
Insider Transaction Report
Form 4
IO Biotech, Inc.IOBT
Smith Devin Whittemore
General Counsel
Transactions
- Award
Stock Option (Right to Buy)
2023-01-12+150,000→ 150,000 totalExercise: $2.60Exp: 2033-01-12→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]One-fourth of these options vest on January 12, 2024, and 1/36th of the remaining options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 25% acceleration upon termination of service by the Issuer without cause and 100% acceleration upon termination of service by the Issuer without cause if such termination occurs within 24 months of a change of control.